In the US, Humira (adalimumab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Juvenile Idiopathic Arthritis, Psoriasis, Psoriatic Arthritis, Reiter's Syndrome and Rheumatoid Arthritis.
US matches:
- Humira
- Humira Pen
- Humira Pen Crohn's Disease Starter Package
UK matches:
- Humira 40 mg solution for injection in pre-filled syringe
- Humira 40mg solution for injection in pre-filled pen
Ingredient matches for Humira
Adalimumab
Adalimumab is reported as an ingredient of Humira in the following countries:
- Argentina
- Australia
- Austria
- Bahrain
- Belgium
- Brazil
- Bulgaria
- Canada
- Chile
- Colombia
- Costa Rica
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Ecuador
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- Ireland
- Israel
- Italy
- Japan
- Luxembourg
- Mexico
- Netherlands
- New Zealand
- Norway
- Oman
- Peru
- Poland
- Portugal
- Singapore
- Slovakia
- Slovenia
- South Africa
- Spain
- Sweden
- Switzerland
- Taiwan
- Turkey
- United Kingdom
- United States
International Drug Name Search